Website Search
Find information on spaces, staff, and services.
Catalog Search
Books
Diabetic cardiology
- Available as
- Online
- Summary
-
With cardiovascular disease becoming the most common cause of death in people with diabetes, interest in the assessment and treatment of heart disease in these patients has been reawakened. This bo...
With cardiovascular disease becoming the most common cause of death in people with diabetes, interest in the assessment and treatment of heart disease in these patients has been reawakened. This book examines developing topics from a largely cardiological perspective, covering both pharmacological and non-pharmacological interventions. The DIGAMI study on the use of intravenous insulin infusion at the time of myocardial infarction (MI) has stimulated a large number of discussion papers on the best treatment of MI in the diabetic patient. The UKPDS has shown that treatment of Type 2 diabetes
Details
- Creator
- editors, Miles Fisher, John J. McMurray
- Format
- Books
- Language
- English
- Contributors
- Publication
-
- 1st ed
- Chichester, England ; Hoboken, N.J. : John Wiley and Sons, c2007
- Series
- Physical Details
-
- 1 online resource (309 p.)
- ISBNs
- 9780470723807, 047086205X, 0470862041, 0470723807, 9780470862049, 1281319783, 9786611319786, 9780470862056
- OCLC
- ocn476170387, ocn214281519, ocn646755373
- Description based upon print version of record.
- Includes bibliographical references and index.
- English
- Diabetic Cardiology; Contents; List of Contributors; Introduction; 1 Epidemiology of Vascular Disease in Diabetes; 1.1 Introduction; 1.2 The Role of Epidemiological Studies; 1.3 Cohort Studies of People with Diabetes; 1.4 Cardiovascular Disease and Diabetes; 1.5 Mortality from Coronary Heart Disease; 1.6 Mortality from Cerebrovascular Disease; 1.7 Discussion; References; 2 Pathogenesis of Atherosclerosis and Vascular Disease in Type 2 Diabetes; 2.1 Introduction; 2.2 What is Insulin Resistance?; 2.3 Dyslipidaemia and Type 2 Diabetes; 2.4 Hypertension
- 2.5 Endothelial Dysfunction and Type 2 Diabetes2.6 Inflammation; 2.7 Adipokines - Adiponectin; 2.8 Haemostatic Changes in Type 2 Diabetes; 2.9 Hyperinsulinaemia; 2.10 Role of Hyperglycaemia; 2.11 Metabolic Syndrome as a Link between Insulin Resistance and CVD?; 2.12 Effects of Anti-diabetic Drugs on Risk Factor Pathways; 2.13 Conclusions; References; 3 Coronary Heart Disease and Diabetes; 3.1 Nature of Coronary Heart Disease in Diabetes; 3.2 Presentation of CHD in Diabetes; 3.3 Non-invasive Investigation; 3.4 Pharmacological Treatment of CHD in People with Diabetes
- 3.5 Coronary Revascularisation in Diabetes3.6 Stents for Coronary Artery Disease in Diabetes; 3.7 Drug-eluting Stents; 3.8 Drug Therapy and PCI in Diabetic Patients; 3.9 Conclusions; References; 4 Diabetes and Acute Coronary Syndromes; 4.1 Introduction; 4.2 Antiplatelet Agents; 4.3 Thrombolysis; 4.4 Beta-blockers; 4.5 ACE Inhibitors; 4.6 Angiotensin Receptor Blockers; 4.7 Heparin; 4.8 Glycoprotein IIb/IIIa Inhibitors; 4.9 Revascularisation for Acute Coronary Syndromes; 4.10 Device Therapy Post-MI; 4.11 Management of Glycaemia; 4.12 Conclusions; References
- 5 Diabetes, Left Ventricular Systolic Dysfunction and Chronic Heart Failure5.1 Introduction; 5.2 Prevalence; 5.3 Incidence; 5.4 Risks of Developing CHF and Diabetes; 5.5 Diabetes and Mortality in Patients with CHF; 5.6 Morbidity; 5.7 Chronic Heart Failure and Abnormalities of Insulin and Glucose Metabolism; 5.8 Why do Patients with Diabetes develop CHF?; 5.9 Reducing the Risk of Diabetes in Patients with CHF; 5.10 Reducing the Development of CHF in Patients with Diabetes; 5.11 Treatment of Diabetes in Patients with CHF; 5.12 Treatment of CHF in Patients with Diabetes; 5.13 Conclusions
- References6 Diabetes and Hypertension; 6.1 Introduction; 6.2 Metabolic Syndrome; 6.3 Risk Stratification; 6.4 Strategies to Reduce Cardiovascular Risk; 6.5 Strategies to Reduce Kidney Disease Risk; 6.6 Risk of Diabetes Mellitus with Antihypertensive Drugs; 6.7 Conclusions; References; 7 Diabetes and Stroke / Transient Ischaemic Attacks; 7.1 Introduction; 7.2 Diabetes as a Risk Factor for Stroke; 7.3 Diabetes, Post-stroke Hyperglycaemia and Outcome from Stroke; 7.4 Hyperglycaemia and Ischaemic Cerebral Damage; 7.5 Management of Diabetes and Hyperglycaemia following Stroke
- 7.6 Prevention of Stroke in Diabetic Patients